Research location
Santiago de Compostela
A Coruña, Spain
Advertisement
Research activity in Santiago de Compostela
A Coruña, SpainCureCurrent currently publishes aggregate city-level research activity for this location: 97 trials and 101 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Santiago de Compostela
71 linked trials · page 1 of 2Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionNCT06736574 · 2024-12-19 · 1 site observation
RECRUITING
GlycOxiTOD: Multimodal Vascular and Target-Organ Damage RegistryNCT06325800 · 2024-01-10 · 1 site observation
RECRUITING
Study of Personalized Allocation of Defibrillators in Non-ischemic Heart Failure (SPANISH-1)NCT06055504 · 2023-09-06 · 1 site observation
RECRUITING
Brief Problem-solving Intervention in Different Formats for the Prevention of Suicide in Adults Over 50NCT06338904 · 2023-09-01 · 1 site observation
RECRUITING
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsNCT05503797 · 2023-02-21 · 1 site observation
RECRUITING
Efficacy and Safety Evaluation for the Treatment of Allergy Against MitesNCT04435990 · 2020-10-06 · 1 site observation
RECRUITING
Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)NCT03711110 · 2019-08-02 · 1 site observation
RECRUITING
Effectiveness of Home-Based Exercise and Brain Stimulation for Reducing Fatigue in Patients With Multiple SclerosisNCT07567989 · 2025-01-01 · 1 site observation
ENROLLING_BY_INVITATION
A Study to Learn How Safe Starting Vericiguat at a Dose of 5 Milligrams is in Participants With Chronic Heart Failure With Reduced Ejection FractionNCT06195930 · 2024-04-18 · 1 site observation
COMPLETED
Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)NCT05853575 · 2024-02-01 · 1 site observation
ACTIVE_NOT_RECRUITING
Prevalence and Impact of Pertussis and RSV on Asthma Severity and ControlNCT06286007 · 2023-12-21 · 1 site observation
UNKNOWN
Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Related to Breast Cancer (ONCODEP)NCT06053775 · 2023-09-27 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local TherapiesNCT05794906 · 2023-04-03 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Learn More About How Well Elinzanetant Works and How Safe it is Compared to Placebo for the Treatment of Hot Flashes Caused by Anti-cancer Therapy in Women With, or at High Risk for Developing Hormone-receptor Positive Breast CancerNCT05587296 · 2022-10-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Morphological Pancreatic Features in Diabetes Mellitus Type 2NCT05762653 · 2022-02-03 · 1 site observation
COMPLETED
SEMAGLUTIDE VERSUS GLP-1 RECEPTOR AGONISTS. EFFECTIVENESS , SAFETY AND QUALITY OF LIFE IN PATIENTS WITH DIABETES MELLITUS 2. OBSERVATIONAL, PROSPECTIVE AND MULTICENTER STUDY. SEVERAL STUDY.NCT05136287 · 2022-02-01 · 1 site observation
COMPLETED
Efficacy & Safety Study of Lorlatinib in ALK/ROS1 Metastatic NSCLC Patients With Compassionate Use TreatmentNCT05167500 · 2021-12-09 · 1 site observation
COMPLETED
Anti-SARS-COV2 Vaccination Study in Lung Cancer PatientsNCT05009030 · 2021-05-06 · 1 site observation
COMPLETED
Locoregional Control With Radiotherapy of Breast Cancer Patients With MACrometastases Treated With MAstectomy (MACMA)NCT06378294 · 2021-04-20 · 1 site observation
ACTIVE_NOT_RECRUITING
Effect of Mepolizumab on Severe Eosinophilic AsthmaNCT04641741 · 2021-04-01 · 1 site observation
UNKNOWN
RADIANT: A Study of Radium-223 Dichloride (Xofigo) vs Enzalutamide or Abiraterone (ARPIs, Androgen Receptor Pathway Inhibitors) in Patients With Prostate Cancer That Has Spread to the Bones (mCRPC, Metastatic Castration-Resistant Prostate Cancer)NCT04597125 · 2020-11-09 · 1 site observation
ACTIVE_NOT_RECRUITING
Neoadjuvant Study Chemotherapy vs Letrozole + Abemaciclib in HR+/HER2- High/Intermediate Risk Breast Cancer PatientsNCT04293393 · 2020-10-02 · 1 site observation
ACTIVE_NOT_RECRUITING
Spanish Real World Data on Patients Treated With Durvalumab After Chemoradiotherapy.NCT04285866 · 2020-05-21 · 1 site observation
COMPLETED
"De Novo" Atrial Fibrillation in Patients With Heart Failure: Incidence; Predictors and Relevance.NCT04755010 · 2019-10-01 · 1 site observation
UNKNOWN
Atezolizumab Plus Bevacizumab in First Line NSCLC PatientsNCT03836066 · 2019-05-15 · 1 site observation
COMPLETED
Exercise-based Cardiac Rehabilitation for the Prevention of Breast Cancer Chemotherapy-induced CardiotoxicityNCT03964142 · 2018-08-01 · 1 site observation
COMPLETED
Patient-reported Outcomes in Vericiguat-treated Patients With HFpEFNCT03547583 · 2018-06-15 · 1 site observation
COMPLETED
Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionSNCT03496766 · 2018-05-07 · 1 site observation
TERMINATED
A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene MutationNCT03439514 · 2018-04-17 · 1 site observation
TERMINATED
T790M Mutation Testing in Blood by Different MethodologiesNCT03363139 · 2018-03-01 · 1 site observation
COMPLETED
Olaparib Maintenance in Patients With MCRPC After Docetaxel Treatment Reaching Partial or Stable Response (IMANOL)NCT03434158 · 2018-02-06 · 1 site observation
COMPLETED
Cognitive-behavioral Intervention Via a Smartphone App for Depressive Symptoms in CaregiversNCT03110991 · 2017-10-01 · 1 site observation
COMPLETED
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsNCT03170960 · 2017-09-05 · 1 site observation
ACTIVE_NOT_RECRUITING
A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Reduced Ejection FractionNCT02992288 · 2017-02-22 · 1 site observation
COMPLETED
Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To MethotrexateNCT02996500 · 2016-11-10 · 1 site observation
COMPLETED
Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)NCT02679170 · 2016-06-29 · 1 site observation
COMPLETED
PROSENZA: Prospective Multi-Centre Study of Prognostic Factors in mCRPC Patients Treated With Enzalutamide.NCT02922218 · 2016-06-01 · 1 site observation
UNKNOWN
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAHNCT02725372 · 2016-04-01 · 1 site observation
TERMINATED
Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid TumorsNCT02715284 · 2016-03-07 · 1 site observation
ACTIVE_NOT_RECRUITING
PRORADIUM: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Radium-223.NCT02925702 · 2016-02-01 · 1 site observation
UNKNOWN
Safety, Tolerability and Efficacy of the Depigmented Modified Allergen Extract of Two Mites in Subjects With Allergic Rhinitis or Rhinoconjunctivitis, With Controlled Allergic AsthmaNCT02340130 · 2014-09-01 · 1 site observation
COMPLETED
PROSABI: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Abiraterone Acetate.NCT02787837 · 2014-05-01 · 1 site observation
UNKNOWN
PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Cabazitaxel.NCT02362620 · 2014-05-01 · 1 site observation
UNKNOWN
Extended Treatment in Metastatic Breast Cancer With EribulinNCT02769364 · 2013-11-01 · 1 site observation
COMPLETED
STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVENCT02328391 · 2013-09-01 · 1 site observation
UNKNOWN
Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesNCT01618370 · 2012-07-22 · 1 site observation
COMPLETED
A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast CancerNCT01525589 · 2012-06-13 · 1 site observation
COMPLETED
Study of Weekly Cabazitaxel for Advanced Prostate CancerNCT01518283 · 2012-05-01 · 1 site observation
COMPLETED
Genotypic Tropism Testing In Proviral Dna To Guide CCR5 Antagonist Treatment In Subjects With Undetectable HIV-1 ViremiaNCT01378910 · 2011-06-01 · 1 site observation
COMPLETED
Intravitreal Aflibercept Injection in Vision Impairment Due to DMENCT01331681 · 2011-05-09 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.